FHA
KRYS icon

First Horizon Advisors’s Krystal Biotech KRYS Stock Holding History

First Horizon Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$33.5K Buy
244
+166
+213% +$24.4K ﹤0.01% 1211
2025
Q1 		$14.1K Buy
+78
New +$13.1K ﹤0.01% 1468
2024
Q2 		– Sell
-24
Closed -$4.27K – 2334
2024
Q1 		$4.27K Buy
+24
New +$3.33K ﹤0.01% 1848

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

First Horizon Advisors's KRYS Position: Q2 2025 in Review

First Horizon Advisors increased its Krystal Biotech (KRYS) stake by 213% in Q2 2025, buying an estimated $24.4K and bringing the position to 244 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

First Horizon Advisors first reported a position in KRYS in Q1 2024 and has held it in 3 quarters since. 275 funds tracked by Wall St. Rank hold KRYS as of Q2 2025.

  • First Horizon Advisors held 244 shares of Krystal Biotech worth $33.5K as of Q2 2025.
  • First Horizon Advisors bought 166 Krystal Biotech shares in Q2 2025, an estimated $24.4K.
  • Krystal Biotech made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1211 holding.
  • First Horizon Advisors first reported a position in Krystal Biotech in Q1 2024 and has held it in 3 quarters since.
  • 275 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.